Novo Holdings reports 1.6% stake in LanzaTech

LanzaTech Global, Inc. disclosure: Novo Holdings A/S reports beneficial ownership of 158,148 shares of LanzaTech common stock, representing 1.6% of the class.

Rhea-AI Filing Summary

LanzaTech Global, Inc. disclosure: Novo Holdings A/S reports beneficial ownership of 158,148 shares of LanzaTech common stock, representing 1.6% of the class. The filing lists Novo Holdings A/S's Denmark address and notes ownership falls under "Ownership of 5 Percent or Less of a Class."

Insights

Institutional Ownership Analyst

Novo Holdings reports a 1.6% stake in LanzaTech (158,148 shares).

Novo Holdings A/S is recorded as beneficial owner of 158,148 shares of common stock, with sole voting and dispositive power over those shares. The filing is an amendment to a Schedule 13G/A and classifies the position as ownership of 5% or less.

Cash‑flow treatment and any acquisition timing are not stated in the excerpt; subsequent filings would be required for changes above the 5% reporting threshold.

Key Figures

Shares reported beneficially owned: 158,148 shares Percent of class: 1.6% CUSIP: 51655R200 +2 more

5 metrics

Shares reported beneficially owned 158,148 shares Schedule 13G/A amendment

Percent of class 1.6% Percent of class reported in Item 4(b)

CUSIP 51655R200 Common Stock CUSIP as listed on the filing

Filing signature date 05/15/2026 Signature date on the amendment

Date noted in header 03/31/2026 Date included near cover/header of the excerpt

Key Terms

Schedule 13G/A, Beneficially owned, CUSIP

3 terms

Schedule 13G/A regulatory

"Amendment No. 1 ) LanzaTech Global, Inc."

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

Beneficially owned financial

"Item 4. | Ownership (a) | Amount beneficially owned: 158,148"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

CUSIP technical

"Common Stock, par value $0.0000001 per share 51655R200"

A CUSIP is a nine-character alphanumeric code that uniquely identifies a U.S. or Canadian financial security—such as a stock, bond, or fund share—like a Social Security number for an investment. It matters to investors because brokers, exchanges and record-keepers use the CUSIP to match trades, track ownership, settle transactions and pull accurate records, reducing errors and ensuring money and securities go to the right place.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does Novo Holdings report in LanzaTech (LNZA)?

Novo Holdings A/S reports beneficial ownership of 158,148 shares of LanzaTech common stock, representing 1.6% of the class. The filing classifies this as ownership of 5 percent or less of the class and lists sole voting and dispositive power.

What voting and dispositive powers does Novo Holdings claim on LNZA shares?

The filing states Novo Holdings A/S holds sole voting power and sole dispositive power over 158,148 shares. Shared voting and shared dispositive powers are listed as 0 in the disclosure.

Which form did Novo Holdings file to report this LNZA position?

Novo Holdings A/S filed an amendment to Schedule 13G/A to report its position in LanzaTech. The filing identifies the position under the rubric "Ownership of 5 Percent or Less of a Class."

What dates and identifiers appear in the LNZA disclosure by Novo Holdings?

The excerpt shows a date entry of 03/31/2026, a signature date of 05/15/2026, and the CUSIP for LanzaTech common stock as 51655R200, all as reported in the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/15/2026 - 04:28 PM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

LanzaTech Global, Inc.

(Name of Issuer)

Common Stock, par value $0.0000001 per share

(Title of Class of Securities)

51655R200

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 51655R200

1

Names of Reporting Persons

Novo Holdings A/S

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DENMARK

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 158,148.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 158,148.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

158,148.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

1.6 %

12

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: LanzaTech Global, Inc.
(b)	Address of issuer's principal executive offices: 8045 Lamon Avenue, Suite 400, Skokie, IL, 60077.
Item 2.
(a)	Name of person filing: Novo Holdings A/S, a Danish corporation, is an investment firm focused on life sciences and finance that is wholly owned by Novo Nordisk Foundation (the "Foundation"), a Danish commercial foundation. Novo Holdings A/S is the holding company in the group of Novo companies, currently comprised of Novo Nordisk A/S and Novozymes A/S (also known as Novonesis A/S), and is responsible for managing the Foundation's assets, including its financial assets. Based on the governance structure of Novo Holdings A/S and the Foundation, the Foundation is not deemed to have any beneficial ownership of the securities of the Issuer held by Novo Holdings A/S.
(b)	Address or principal business office or, if none, residence: Tuborg Havnevej 19 2900 Hellerup, Denmark
(c)	Citizenship: Denmark
(d)	Title of class of securities: Common Stock, par value $0.0000001 per share
(e)	CUSIP No.: 51655R200
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 158,148
(b)	Percent of class: 1.6%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 158,148
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 158,148
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Novo Holdings A/S

Signature:	Barbara Fiorini
Name/Title:	Barbara Fiorini, General Counsel, Finance & Operations
Date:	05/15/2026